Lisa Cook has warned that the Federal Reserve is increasingly concerned about rising inflation risks due to the ongoing Iran conflict. While the labour market remains broadly stable, she noted it is fragile and could weaken if higher costs start impacting business activity.Read More
Mankind Pharma share price surged 2% after Morgan Stanley initiated coverage with an ‘Overweight’ rating and a Rs 2,500 target price, citing strong growth potential. The brokerage anticipates robust revenue and EPS growth driven by domestic business recovery and the BSV segment, favoring Mankind Pharma for its favorable risk-reward profile.Read More
DBS Group Holdings Ltd. has launched its equity capital market operations in India. The Singaporean lender secured its first deal with Manipal Health Enterprises Pvt. for a $1 billion initial public offering. This move signals DBS’s strong commitment to India’s growing capital markets. The bank aims to provide a full suite of investment banking services to Indian businesses and investors.Read More
Indian equity investors faced losses while international funds delivered triple-digit returns in FY26, driven by global tech growth and commodity price surges. While domestic schemes struggled, international investments showcased the benefits of global diversification, though experts advise against chasing past performance and advocate for a balanced portfolio allocation.Read More
Life Insurance Corporation of India (LIC) shares are under scrutiny after the company disclosed an income tax demand order of Rs 7,100 crore for FY22. The demand includes Rs 6,147 crore in tax and Rs 953 crore in interest, stemming from various alleged violations. LIC stated the order is appealable and will not materially impact its operations.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
